Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Basmisanil (RG1662) is a negative allosteric modulator/inverse agonist of GABAAα5 receptors.Formulations containing basmisanil are in clinical trials for the treatment of cognitive impairments associated with Down syndrome.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 32.00 | |
5 mg | In stock | $ 51.00 | |
10 mg | In stock | $ 72.00 | |
25 mg | In stock | $ 125.00 | |
50 mg | In stock | $ 207.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 43.00 |
Description | Basmisanil (RG1662) is a negative allosteric modulator/inverse agonist of GABAAα5 receptors.Formulations containing basmisanil are in clinical trials for the treatment of cognitive impairments associated with Down syndrome. |
Synonyms | RG1662, RO5186582 |
Molecular Weight | 445.46 |
Formula | C21H20FN3O5S |
CAS No. | 1159600-41-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 32 mg/mL (71.84 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Basmisanil 1159600-41-5 Membrane transporter/Ion channel Neuroscience GABA Receptor α subunit-containing GABAA receptors (GABAAα5) psychiatric disorders RG1662 negative allosteric modulator (NAMs) γ-Aminobutyric acid Receptor cognitive Inhibitor RG-1662 Gamma-aminobutyric acid Receptor RO 5186582 RO5186582 RG 1662 inhibit RO-5186582 inhibitor